Study of an Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stone Disease

NCT04771182 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2026-04-03

Study results available
· View outcomes & findings →

Summary

This is a single arm, multi-center study to assess the safety and efficacy of a form of extracorporeally induced lithotripsy, called the Enhanced Lithotripsy System, to treat urinary stones.

Conditions

  • Urinary Stone

Interventions

DEVICE

Enhanced Lithotripsy System

Treatment of urinary stone disease with the Enhanced Lithotripsy System

Sponsors & Collaborators

  • Avvio Medical

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-08
Primary Completion
2020-03-18
Completion
2022-10-05
FDA Device
Yes

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04771182 on ClinicalTrials.gov